Zobrazeno 1 - 10
of 228
pro vyhledávání: '"J.-M. Suc"'
Autor:
F. Mignon, Michel Godin, D. Durand, N. El Esper, T. Hannedouche, J.-M. Suc, P. Landais, Jean-Pierre Grünfeld, B. Goldfarb, J. Chanard, A. Fournier
Publikováno v:
BMJ. 309:833-837
Objective: To compare the ability of angiotensin converting enzyme inhibitors and β blockers to slow the development of end stage renal failure in non-diabetic patients with chronic renal failure. Design: Open randomised multicentre trial with three
Publikováno v:
American Journal of Nephrology. 11:501-504
We report 3 patients who developed signs of systemic infection and renal insufficiency after intravesical bacillus Calmette-Guérin (BCG) instillations for a bladder cancer. Renal biopsy showed tubulo-interstitial nephritis with or without epithelioi
Publikováno v:
Annales de cardiologie et d'angeiologie. 47(8)
31 male and female patients, between the ages of 18 and 65 years, presenting mild-to-moderate hypertension (DBP between 95 and 114 mmHg) and stable chronic renal failure (creatinine clearance between 60 and 25 ml/min) after a preinclusion placebo pha
Publikováno v:
Annales de biologie clinique. 56(3)
Autor:
J M, Suc
Publikováno v:
Nephrologie. 19(3)
Autor:
L, Rostaing, J, Izopet, F, Moussion, L, Alric, D, Verdier, H T, That, M, Duffaut, D, Durand, J, Puel, J M, Suc
Publikováno v:
Nephrologie. 18(7)
Patients on maintenance hemodialysis are frequently infected with hepatitis C virus (HCV). The long-term effect of alpha interferon therapy has not yet been assessed, or the influence of co-infection with the newly discovered hepatitis G/hepatitis GB
Publikováno v:
La Revue du praticien. 46(15)
Publikováno v:
Nephrologie. 17(3)
Autor:
Jacques Izopet, J. M. Suc, Lionel Rostaing, Dominique Durand, Chabannier Mh, Jean-Marc Cisterne, Michel Duffaut, E. Baron
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 11
We studied the prevalence of HCV infection in a cohort of 346 patients who received renal transplantation between January 1989 and April 1994. Assessments were made at the time of surgery, one year later and at the last follow-up visit. The hepatic c
Autor:
L, Rostaing, A, Modesto, E, Baron, J M, Cisterne, M H, Chabannier, J, Tkaczuk, D, Durand, J M, Suc
Publikováno v:
Nephrologie. 17(4)
Sixteen renal transplant (RT) patients (10 men, 6 women, aged 49 +/- 10 years) with chronic hepatitis C received alpha interferon (IFN alpha) therapy (Intron A, Schering Plough) at a dose of 3 x 10(6) units s.c. 3 times a week, scheduled for 24 conse